Literature DB >> 33876959

Rationally Designed Base Editors for Precise Editing of the Sickle Cell Disease Mutation.

S Haihua Chu1, Michael Packer1, Holly Rees1, Dieter Lam1, Yi Yu1, Jeffrey Marshall1, Lo-I Cheng1, Daisy Lam1, Jenny Olins1, Fei Ann Ran1, Alexander Liquori1, Bob Gantzer1, Jeremy Decker1, David Born1, Luis Barrera1, Adam Hartigan1, Nicole Gaudelli1, Giuseppe Ciaramella1, Ian M Slaymaker1.   

Abstract

Base editors are fusions of a deaminase and CRISPR-Cas ribonucleoprotein that allow programmable installment of transition mutations without double-strand DNA break intermediates. The breadth of potential base editing targets is frequently limited by the requirement of a suitably positioned Cas9 protospacer adjacent motif. To address this, we used structures of Cas9 and TadA to design a set of inlaid base editors (IBEs), in which deaminase domains are internal to Cas9. Several of these IBEs exhibit shifted editing windows and greater editing efficiency, enabling editing of targets outside the canonical editing window with reduced DNA and RNA off-target editing frequency. Finally, we show that IBEs enable conversion of the pathogenic sickle cell hemoglobin allele to the naturally occurring HbG-Makassar variant in patient-derived hematopoietic stem cells.

Entities:  

Year:  2021        PMID: 33876959     DOI: 10.1089/crispr.2020.0144

Source DB:  PubMed          Journal:  CRISPR J        ISSN: 2573-1599


  15 in total

1.  dCas9 binding inhibits the initiation of base excision repair in vitro.

Authors:  Jacob S Antony; Steven A Roberts; John J Wyrick; John M Hinz
Journal:  DNA Repair (Amst)       Date:  2021-11-20

Review 2.  Editing outside the body: Ex vivo gene-modification for β-hemoglobinopathy cellular therapy.

Authors:  Tolulope O Rosanwo; Daniel E Bauer
Journal:  Mol Ther       Date:  2021-10-08       Impact factor: 11.454

Review 3.  CRISPR-derived genome editing therapies: Progress from bench to bedside.

Authors:  Holly A Rees; Alex C Minella; Cameron A Burnett; Alexis C Komor; Nicole M Gaudelli
Journal:  Mol Ther       Date:  2021-10-05       Impact factor: 11.454

4.  Adenine Base Editing In Vivo with a Single Adeno-Associated Virus Vector.

Authors:  Han Zhang; Nathan Bamidele; Pengpeng Liu; Ogooluwa Ojelabi; Xin D Gao; Tomás Rodriguez; Haoyang Cheng; Karen Kelly; Jonathan K Watts; Jun Xie; Guangping Gao; Scot A Wolfe; Wen Xue; Erik J Sontheimer
Journal:  GEN Biotechnol       Date:  2022-06-14

5.  Efficient in vivo base editing via single adeno-associated viruses with size-optimized genomes encoding compact adenine base editors.

Authors:  Jessie R Davis; Xiao Wang; Isaac P Witte; Tony P Huang; Jonathan M Levy; Aditya Raguram; Samagya Banskota; Nabil G Seidah; Kiran Musunuru; David R Liu
Journal:  Nat Biomed Eng       Date:  2022-07-28       Impact factor: 29.234

6.  Engineered LwaCas13a with enhanced collateral activity for nucleic acid detection.

Authors:  Jie Yang; Yang Song; Xiangyu Deng; Jeffrey A Vanegas; Zheng You; Yuxuan Zhang; Zhengyan Weng; Lori Avery; Kevin D Dieckhaus; Advaith Peddi; Yang Gao; Yi Zhang; Xue Gao
Journal:  Nat Chem Biol       Date:  2022-09-22       Impact factor: 16.174

7.  High-throughput continuous evolution of compact Cas9 variants targeting single-nucleotide-pyrimidine PAMs.

Authors:  Tony P Huang; Zachary J Heins; Shannon M Miller; Brandon G Wong; Pallavi A Balivada; Tina Wang; Ahmad S Khalil; David R Liu
Journal:  Nat Biotechnol       Date:  2022-09-08       Impact factor: 68.164

Review 8.  In vivo somatic cell base editing and prime editing.

Authors:  Gregory A Newby; David R Liu
Journal:  Mol Ther       Date:  2021-09-10       Impact factor: 11.454

Review 9.  Understanding and overcoming adverse consequences of genome editing on hematopoietic stem and progenitor cells.

Authors:  Byung-Chul Lee; Richard J Lozano; Cynthia E Dunbar
Journal:  Mol Ther       Date:  2021-09-10       Impact factor: 11.454

10.  Base editing of haematopoietic stem cells rescues sickle cell disease in mice.

Authors:  Gregory A Newby; Jonathan S Yen; Kaitly J Woodard; Thiyagaraj Mayuranathan; Cicera R Lazzarotto; Yichao Li; Heather Sheppard-Tillman; Shaina N Porter; Yu Yao; Kalin Mayberry; Kelcee A Everette; Yoonjeong Jang; Christopher J Podracky; Elizabeth Thaman; Christophe Lechauve; Akshay Sharma; Jordana M Henderson; Michelle F Richter; Kevin T Zhao; Shannon M Miller; Tina Wang; Luke W Koblan; Anton P McCaffrey; John F Tisdale; Theodosia A Kalfa; Shondra M Pruett-Miller; Shengdar Q Tsai; Mitchell J Weiss; David R Liu
Journal:  Nature       Date:  2021-06-02       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.